Table 3.
Different doses of enoxaparin and fondaparinux in patients with COVID-19 at baseline with occurrence of vein-thrombosis events (VTEs)
| n | Type of VTE | Clinical signs of suspected VTE | |
|---|---|---|---|
| Enoxaparin twice daily after VTE diagnosis | 5 | Three proximal DVT, one IDVT, one SVT, four f them with PE | Twosymptomatic DVT, two asymptomatic IDVT and SVT |
| Fondaparinux therapeutic dosage after VTE diagnosis | 2 | 2 proximal DVT | Two symptomatic DVT |
Abbreviations: DVT, deep-vein thrombosis; IDVT, isolated DVT; SVT, superficial VT; PE, pulmonary embolism.